Susceptibility of Primary HTLV-1 Isolates from Patients with HTLV-1-Associated Myelopathy to Reverse Transcriptase Inhibitors

Since human T-lymphotropic virus type 1 (HTLV-1)-associated diseases are associated with a high HTLV-1 load, reducing this load may treat or prevent disease. However, despite in vitro evidence that certain nucleoside/nucleotide analogue reverse transcriptase inhibitors (NRTIs) are active against HTL...

Descripción completa

Detalles Bibliográficos
Autores principales: Macchi, Beatrice, Balestrieri, Emanuela, Ascolani, Arianna, Hilburn, Silva, Martin, Fabiola, Mastino, Antonio, Taylor, Graham P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185762/
https://www.ncbi.nlm.nih.gov/pubmed/21994743
http://dx.doi.org/10.3390/v3050469

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185762/
https://www.ncbi.nlm.nih.gov/pubmed/21994743
http://dx.doi.org/10.3390/v3050469

Ejemplares similares